Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Grows By 59.6%

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the target of a large growth in short interest in January. As of January 15th, there was short interest totaling 10,560 shares, a growth of 59.6% from the December 31st total of 6,618 shares. Currently, 3.8% of the company’s stock are short sold. Based on an average trading volume of 15,067 shares, the days-to-cover ratio is currently 0.7 days. Based on an average trading volume of 15,067 shares, the days-to-cover ratio is currently 0.7 days. Currently, 3.8% of the company’s stock are short sold.

ProShares UltraShort Nasdaq Biotechnology Stock Up 2.0%

Shares of ProShares UltraShort Nasdaq Biotechnology stock traded up $0.18 on Friday, reaching $8.99. The company’s stock had a trading volume of 6,652 shares, compared to its average volume of 16,678. The firm’s fifty day simple moving average is $9.27 and its two-hundred day simple moving average is $11.88. ProShares UltraShort Nasdaq Biotechnology has a 52 week low of $8.37 and a 52 week high of $25.87.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 31st. Investors of record on Wednesday, December 24th were paid a $0.1026 dividend. The ex-dividend date was Wednesday, December 24th. This represents a $0.41 dividend on an annualized basis and a yield of 4.6%.

Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Csenge Advisory Group acquired a new stake in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 12,421 shares of the company’s stock, valued at approximately $163,000. Csenge Advisory Group owned approximately 6.54% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent reporting period.

About ProShares UltraShort Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.